Dr. Daniel Weiss MD

President, Weiss Consulting Groups, Inc.

GLG News by Dr. Daniel Weiss MD, President

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Medtronic - the new Guidant?

October 18, 2007

Analysis of:Medtronic Pulls Heart Device Wires | www.thestreet.com

The current recall is yet another in the world of cardiac rhythm devices. The ICD market is already shakey and may be adversely affected. Will Medtronic's reputation suffer?

TB-402 - the type of anticoagulant patients and physicians are looking for as a warfarin replacement

September 17, 2007

Analysis of:ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402 | www.pipelinereview.com

TB-402 is a new anticoagulant candidate that seeks to fill a desperate unmet need in a variety of different medical conditions. It would be easily administered with a low risk of patient noncompliance, have reversible effects, and potentially safer than currently available alternatives.

Page : 11 to 2 of 2

Subscribe to Updates

By RSS